期刊文献+

帕金森病药物治疗的个性化方案选择及其思考 被引量:4

Individulization of Drug Therapy of Parkinson's Disease: Selection and Thought
暂未订购
导出
作者 钟春玖
出处 《中国临床医学》 2004年第3期275-277,共3页 Chinese Journal of Clinical Medicine
  • 相关文献

参考文献11

  • 1Agid Y, Olanow CW, Mizuno Y. Levodopa: why the controversy? Lancet, 2002,360 : 575.
  • 2Barone P. Clinical strategies to prevent and delay motor complications. Neurology, 2003, 61(Suppl 3) : s12- s16.
  • 3Datla KP, Blunt SB, Dexter DT. Chronic L- DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6- OHDA or FeCl3 nigrostriatal lesions. Mov Disord, 200
  • 4Hubble J, Guarnieri M, Olanow CW. Effects of entacapone in Parkinson's disease patients without end of dose wearing off.Neurology, 2003, 60:289-290.
  • 5Koller WC, Tse W. Unmet medical needs in Parkinson's disease. Neurology, 2004, 62(Suppl1): s1 - s8.
  • 6Lewitt PA, Nyholm D. New developments in levodopa therapy.Neurology, 2004, 62(Suppl 1):s9-s16.
  • 7Maratos EC, Jackson MJ, Pearce RK, et al. Botj short- and long - acting D - 1/D - 2 dopamine agonists induce less dyskinesia than L- DOPA in the MPTP - lesioned common marmoset (Callithrix jacchus). Exp Neurol, 2003, 179:90~ 102.
  • 8Mytilineou C, Walker RH, Jno Baptiste R, et al. Levodopa is toxic to dopamine neurons in an in vitro but not in an in vivo model of oxidative stress. J Pharmacol Exp Ther, 2003, 304:792-800.
  • 9Poewe W. The role of COMT inhibition in the treatment of Parkinson's disease. Neurology, 2004, 62 (Suppl 1): s31 - s38.
  • 10Rogers JD, Sanchez- Saffon A, Frol AB, et al. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol, 2003, 60:59-64.

同被引文献34

  • 1肖爱华.护理干预对帕金森氏病出院病人日常生活能力的影响[J].护理实践与研究,2005,2(6):7-8. 被引量:5
  • 2金莉蓉,洪震,钟春玖,汪洋.骨髓间质干细胞对MPP^+损伤离体大鼠纹状体-黑质脑片的作用[J].中国病理生理杂志,2007,23(4):729-733. 被引量:2
  • 3Evans A M.Influence of dietary components on the gastrointestinal metabolism and transport of drugs[J].Ther Drug Monit,2000,22(1):131-136.
  • 4Gu C H,Li H,Levons J,et al.Predicting effect of food on extent of drug absorption based on physicochemical properties[J].Pharm Res,2007,24(6):1118-1130.
  • 5Singh B N.Effects of food on clinical pharmacokinetics[J].Clin Pharmacokinet,1999,37(3):213-255.
  • 6Welling P G.Effects of food on drug absorption[J].Annu Rev Nutr,1996,16:383-415.
  • 7Sugano K,Kataoka M,Mathews Cda C,et al.Prediction of food effect by bile micelles on oral drug absorption considering free fraction in intestinal fluid[J].Eur J Pharm Sci,2010,40(2):118-124.
  • 8Persson E M,Nordgren A,Forsell P,et al.Improved understanding of the effect of food on drug absorption and bioavailability for lipophilic compounds using an intestinal pig perfusion model[J].Eur J Pharm Sci,2008,34(1):22-29.
  • 9Mangano N G,Cutuli V M,Caruso A,et a1.Grapefruit juice effects on the bioavailability of cyclosporine-A in rats[J].Eur Rev Med Pharmacol Sci,2001,5(1):1-6.
  • 10Gai M N,Ferj S,Garcia E,et al.Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets.Effect of different diets on the bioavailability[J].Drug Dev Ind Pharm,1999,25(2):131-140.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部